These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CHEMOTHERAPY WITH SECONDARY DRUGS IN THE FAR ADVANCED CASES OF PULMONARY TUBERCULOSIS. OKA S Sci Rep Res Inst Tohoku Univ Med; 1965 Mar; 12():1-31. PubMed ID: 14331173 [No Abstract] [Full Text] [Related]
4. CHEMOTHERAPY OF PULMONARY TUBERCULOSIS IN ADULTS: THE CHOICE OF DRUGS IN RELATION TO DRUG SUSCEPTIBILITY. A STATEMENT OF THE COMMITTEE ON THERAPY. TSUKAMURA M Am Rev Respir Dis; 1965 Sep; 92():508-12. PubMed ID: 14346379 [No Abstract] [Full Text] [Related]
5. OPTIMAL REGIMENS OF CHEMOTHERAPY IN PATIENTS ALREADY TREATED, WITH BACILLI RESISTANT TO THE MAJOR ANTITUBERCULOUS DRUGS. TUCKER B Bull Int Union Tuberc; 1964 Sep; 35():151-5. PubMed ID: 14269363 [No Abstract] [Full Text] [Related]
6. [Chemotherapy and drug resistance of pathogens]. Rische H; Tschäpe H Dtsch Gesundheitsw; 1972 Nov; 27(48):2296-9. PubMed ID: 4348270 [No Abstract] [Full Text] [Related]
7. Sensitivity tests by disc method as a guide for chemotherapy. TUNEVALL G; ERICSSON H Antibiot Chemother (Northfield); 1954 Aug; 4(8):886-93. PubMed ID: 24543215 [No Abstract] [Full Text] [Related]
8. [PROBLEMS OF CHRONIC TUBERCULOSIS. DETERMINATION OF RESISTANCE IN TREATMENT WITH SECONDARY DRUGS]. KREBS A Z Tuberk Erkr Thoraxorg; 1964 Oct; 122():141-53. PubMed ID: 14330257 [No Abstract] [Full Text] [Related]
10. [THE PRACTICAL CONSEQUENCES OF PRIMARY RESISTANCE OF KOCH'S BACILLUS TO ANTI-BACILLI DRUGS]. BERNARD E; KREIS B Rev Prat; 1965 Jan; 15():275-82. PubMed ID: 14251074 [No Abstract] [Full Text] [Related]
11. [The troublesome progress of chemotherapy]. Lang W MMW Munch Med Wochenschr; 1977 Oct; 119(42):1347-8. PubMed ID: 412068 [No Abstract] [Full Text] [Related]
12. [Factors determining resistance to the action of chemotherapeutics and antibiotics]. KEMPSKI HW Sem Med; 1953 Feb; 102(9):274-7. PubMed ID: 13076490 [No Abstract] [Full Text] [Related]
13. Control of chemotherapy. Lancet; 1969 May; 1(7601):930-1. PubMed ID: 4180905 [No Abstract] [Full Text] [Related]
15. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE. KASS I Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964 [No Abstract] [Full Text] [Related]
16. [Problems in chemotherapy in hospitals and private practice]. Metz H Ther Ggw; 1981 Dec; 120(12):1126-9. PubMed ID: 7330783 [No Abstract] [Full Text] [Related]
17. [STUDIES ON THE TRANSITION OF SENSITIVITY FOR SM, INH AND PAS OF TUBERCLE BACILLI ISOLATED FROM THE PATIENTS TREATED BY TRIPLE COMBINATION CHEMOTHERAPY INCLUDING SM AND INH WITH SPECIAL REFERENCE TO THEIR CLINICAL COURSE]. OHSATO T; SHIMIZU H Kekkaku; 1965 Jan; 40():19-24. PubMed ID: 14288528 [No Abstract] [Full Text] [Related]
18. Principles of combination chemotherapy. Ambrus JL; Ambrus CM Am J Pharm Sci Support Public Health; 1970; 142(3):116-26. PubMed ID: 5514870 [No Abstract] [Full Text] [Related]
19. [Basic trends and the prospects for creating new synthetic chemotherapeutic preparations]. Pershin GN Antibiotiki; 1980 Oct; 25(10):723-9. PubMed ID: 7425591 [TBL] [Abstract][Full Text] [Related]